{"corpus_id":36620872,"paper_sha":"8004b6724ef9b8b7436b1989ee23e563299d499a","doi":"10.1074/jbc.M209863200","arxiv_id":null,"pmid":12496277,"pmcid":null,"mag_id":1975584470,"dblp_id":null,"acl_id":null,"title":"Identification of Gene-selective Modulators of the Bile Acid Receptor FXR*","year":2003,"publication_date":"2003-02-28","venue":"Journal of Biological Chemistry","journal":{"name":"The Journal of Biological Chemistry","pages":"7027 - 7033","volume":"278"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, U.S. Gov't, P.H.S."],"s2_fields_of_study":["Biology","Medicine","Chemistry"],"reference_count":39,"citation_count":103,"influential_citation_count":1,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Animals","mj":false,"ui":"D000818"},{"d":"Bile Acids and Salts","mj":false,"qs":[{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D001647"},{"d":"Binding, Competitive","mj":false,"ui":"D001667"},{"d":"Blotting, Northern","mj":false,"ui":"D015152"},{"d":"Caprylates","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"}],"ui":"D002210"},{"d":"Cholesterol","mj":false,"qs":[{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D002784"},{"d":"Cholesterol 7-alpha-Hydroxylase","mj":false,"qs":[{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D002790"},{"d":"DNA-Binding Proteins","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D004268"},{"d":"Dose-Response Relationship, Drug","mj":false,"ui":"D004305"},{"d":"Drug Design","mj":false,"ui":"D015195"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Ligands","mj":false,"ui":"D008024"},{"d":"Models, Chemical","mj":false,"ui":"D008956"},{"d":"Phenyl Ethers","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"}],"ui":"D010647"},{"d":"Protein Structure, Tertiary","mj":false,"ui":"D017434"},{"d":"Receptors, Cytoplasmic and Nuclear","mj":false,"ui":"D018160"},{"d":"Transcription Factors","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D014157"},{"d":"Transcription, Genetic","mj":false,"ui":"D014158"},{"d":"Transfection","mj":false,"ui":"D014162"},{"d":"Receptor, Farnesoid X-Activated","mj":false,"ui":"D000099150"}],"chemicals":[{"n":"Bile Acids and Salts","ui":"D001647","reg":"0"},{"n":"Caprylates","ui":"D002210","reg":"0"},{"n":"Cholesterol","ui":"D002784","reg":"97C5T2UQ7J"},{"n":"Cholesterol 7-alpha-Hydroxylase","ui":"D002790","reg":"EC 1.14.14.23"},{"n":"DNA-Binding Proteins","ui":"D004268","reg":"0"},{"n":"Ligands","ui":"D008024","reg":"0"},{"n":"Phenyl Ethers","ui":"D010647","reg":"0"},{"n":"Receptors, Cytoplasmic and Nuclear","ui":"D018160","reg":"0"},{"n":"Transcription Factors","ui":"D014157","reg":"0"},{"n":"Receptor, Farnesoid X-Activated","ui":"D000099150","reg":"0"},{"n":"AGN 34 compound","ui":"C472778","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"http://www.jbc.org/article/S0021925819326316/pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/8004b6724ef9b8b7436b1989ee23e563299d499a","s2_open_access_license":"CCBY","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"BAR is a nuclear bile acid receptor (BAR) (FXR) receptor that regulates gene networks involved in cholesterol and bile acid homeostasis. We have identified two classes of synthetic compounds that differentially modulate BAR activity. The first class activates BAR target genes in the predicted fashion and is 25-fold more potent than endogenous bile acids. The second class, represented by AGN34, antagonizes BAR in transient reporter assays. Surprisingly, this compound acts in a gene-selective manner in vivo: it is an agonist on CYP7A1, an antagonist on IBABP , and is neutral on SHP. These findings indicate that synthetic BAR modulators can be developed to regulate transcription in a gene-specific fashion. Given the ability of BAR to regulate several lipid homeostatic pathways, the identification of gene-selective BAR modulators have important implications for the development of improved cholesterol lowering agents.","claims":[{"public_id":"cl_37607c8c7ffd3f9ee37f9e4656136020","status":"active","text":"AGN34 acts in a gene-selective manner in vivo, functioning as an agonist on CYP7A1, an antagonist on IBABP, and remaining neutral on SHP.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_37607c8c7ffd3f9ee37f9e4656136020"},{"public_id":"cl_afec31cf3557822ba886ccc6479a780a","status":"active","text":"AGN34 antagonizes FXR in transient reporter assays.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_afec31cf3557822ba886ccc6479a780a"},{"public_id":"cl_8e0acc2c505a9e128767f7b36bff151f","status":"active","text":"Synthetic FXR modulators can be developed to regulate transcription in a gene-specific fashion.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_8e0acc2c505a9e128767f7b36bff151f"},{"public_id":"cl_78584cd5c79f7bc5455dd612841b5416","status":"active","text":"Two classes of synthetic compounds differentially modulate FXR activity, with one class activating target genes and showing 25-fold greater potency than endogenous bile acids.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_78584cd5c79f7bc5455dd612841b5416"}],"concepts":[{"public_id":"co_1d667ac4ce011519b4ea11857bb1c0e7","status":"active","name":"transcription","description":"Gene expression at the RNA synthesis level, which FXR-modulating compounds are used to regulate.","types":["biological process"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_1d667ac4ce011519b4ea11857bb1c0e7"},{"public_id":"co_2a98c29c61303851132f137d70288279","status":"active","name":"FXR","description":"A nuclear bile acid receptor that regulates gene networks involved in cholesterol and bile acid homeostasis.","types":["receptor","nuclear receptor"],"aliases":["BAR","farnesoid X receptor"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_2a98c29c61303851132f137d70288279"},{"public_id":"co_37e0d6c6fdc5eeeeb74a6e486093fb1b","status":"active","name":"cholesterol lowering agents","description":"Therapeutic agents intended to reduce cholesterol levels.","types":["therapeutic agent"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_37e0d6c6fdc5eeeeb74a6e486093fb1b"},{"public_id":"co_52b015930af5e1d8b7d37fbbfaa7532d","status":"active","name":"IBABP","description":"A gene encoding ileal bile acid-binding protein, used here as an FXR-regulated transcriptional target.","types":["gene","target gene"],"aliases":["ileal bile acid-binding protein"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_52b015930af5e1d8b7d37fbbfaa7532d"},{"public_id":"co_74860d61149b2c60f90e74171c76513a","status":"active","name":"transient reporter assays","description":"Short-term cell-based assays used to measure receptor-dependent transcriptional activity.","types":["assay","reporter assay"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_74860d61149b2c60f90e74171c76513a"},{"public_id":"co_7cc4c90c229c46dd6cff63405aade934","status":"active","name":"SHP","description":"A gene encoding small heterodimer partner, used here as an FXR-regulated transcriptional target.","types":["gene","target gene"],"aliases":["small heterodimer partner"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7cc4c90c229c46dd6cff63405aade934"},{"public_id":"co_b30fd2a74c03f0beae4553b07f53ef42","status":"active","name":"CYP7A1","description":"A gene encoding cholesterol 7 alpha-hydroxylase, used here as an FXR-regulated transcriptional target.","types":["gene","target gene"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b30fd2a74c03f0beae4553b07f53ef42"},{"public_id":"co_ca0ba223e0d36c4d685afff30c7a5d2f","status":"active","name":"gene-selective modulators","description":"Compounds that modulate receptor activity differently across individual target genes.","types":["modulator","selective modulator"],"aliases":["gene-selective BAR modulators"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ca0ba223e0d36c4d685afff30c7a5d2f"},{"public_id":"co_d6f1db84f2bf51cbf5ee5b933b9ee465","status":"active","name":"synthetic compounds","description":"Artificially designed small molecules used here to modulate FXR activity.","types":["compound","modulator"],"aliases":["synthetic BAR modulators"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d6f1db84f2bf51cbf5ee5b933b9ee465"},{"public_id":"co_db3da67ce61ac57667c18ed182113525","status":"active","name":"endogenous bile acids","description":"Naturally occurring bile acids that serve as the endogenous ligands for FXR.","types":["ligand","metabolite"],"aliases":["bile acids"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_db3da67ce61ac57667c18ed182113525"},{"public_id":"co_f1c5d25826eff5f7a2baa030a8769250","status":"active","name":"AGN34","description":"A synthetic compound identified as a BAR/FXR modulator and used as a representative of the second compound class.","types":["compound","modulator"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f1c5d25826eff5f7a2baa030a8769250"}],"external_ids":{"DOI":"10.1074/jbc.M209863200","ArXiv":null,"PubMed":12496277,"PubMedCentral":null,"MAG":1975584470,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"http://www.jbc.org/article/S0021925819326316/pdf","landing_url":"https://www.semanticscholar.org/paper/8004b6724ef9b8b7436b1989ee23e563299d499a","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":630744,"paper_uid":"59d0a7d4-2836-4270-af94-c8314548f6c8","canonical_identity":{"paper_id":630744,"paper_uid":"59d0a7d4-2836-4270-af94-c8314548f6c8","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/36620872"}